Vanguard reports 10.1% stake in Johnson & Johnson
The Vanguard Group reports beneficial ownership of 243,455,135 shares of Johnson & Johnson common stock, representing 10.1% of the class as of 01/30/2026.
Rhea-AI Filing Summary
The Vanguard Group reports beneficial ownership of 243,455,135 shares of Johnson & Johnson common stock, representing 10.1% of the class as of 01/30/2026.
Vanguard has no sole voting or dispositive power. It has shared voting power over 24,005,159 shares and shared dispositive power over all 243,455,135 shares. The shares are held for clients, who are entitled to dividends and sale proceeds, with no single client holding more than 5% of the class.
Vanguard states the position is held in the ordinary course of business and not to change or influence control of Johnson & Johnson. Following an internal realignment on 01/12/2026, certain Vanguard subsidiaries or business divisions may report beneficial ownership separately while pursuing the same investment strategies as before.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much Johnson & Johnson (JNJ) stock does The Vanguard Group report owning?
Is Vanguard’s Johnson & Johnson stake a passive investment?
How does Vanguard’s internal realignment affect its JNJ ownership reporting?
Who ultimately benefits from Vanguard’s Johnson & Johnson holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.